Search

Search Constraints

You searched for: Author/Creator de Lavallade, Hugues

Search Results

1. A British Society for Haematology Guideline on the diagnosis and management of chronic myeloid leukaemia. (30th July 2020)

2. Alemtuzumab vs anti‐thymocyte globulin in patients transplanted from an unrelated donor after a reduced intensity conditioning. (18th September 2018)

3. Anti‐type M phospholipase A2 receptor antibody‐positive membranous nephropathy as a part of multi‐system autoimmune syndrome post‐allogeneic stem cell transplantation. Issue 4 (6th April 2018)

4. Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio‐Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio‐Oncology Society. (6th August 2020)

5. Chronic myeloid leukaemia patients at diagnosis and resistant to tyrosine kinase inhibitor therapy display exhausted T‐cell phenotype. (8th July 2022)

6. Comparative analysis of melphalan versus busulphan T‐cell deplete conditioning using alemtuzumab in unrelated donor stem cell transplantation for acute myeloid leukaemia. (8th August 2019)

7. De-escalation of tyrosine kinase inhibitor dose in patients with chronic myeloid leukaemia with stable major molecular response (DESTINY): an interim analysis of a non-randomised, phase 2 trial. Issue 7 (July 2017)

8. De-escalation of tyrosine kinase inhibitor therapy before complete treatment discontinuation in patients with chronic myeloid leukaemia (DESTINY): a non-randomised, phase 2 trial. Issue 7 (July 2019)

9. Early and late‐onset veno‐occlusive disease/sinusoidal syndrome post allogeneic stem cell transplantation – a real‐world UK experience. Issue 2 (20th November 2020)

10. Effect of low-level BCR-ABL1 kinase domain mutations identified by next-generation sequencing in patients with chronic myeloid leukaemia: a population-based study. Issue 5 (May 2019)